For researchers
Determining how best to slow, stop or reverse Parkinson’s needs world-class collaborative science involving researchers, clinicians, the pharmaceutical industry and, most importantly, people who are living with Parkinson’s. This collaboration is at the heart of our research programme.
Our research strategy
Our goal is to cure Parkinson’s, with urgency, for people currently living with the condition. By “cure”, Cure Parkinson’s means disease-modifying therapy or therapies. Cure Parkinson’s does not fund research which is directed only to symptomatic relief. This means that the research we fund must aim to slow, stop or reverse underlying disease progression.
Our Research Strategy
Apply for funding
We fund both preclinical and clinical research projects that have the potential to cure Parkinson’s. By “cure”, we mean a “disease-modifying therapy” that will slow, stop or reverse the underlying disease progression of Parkinson’s. In addition, we prioritise research which has the potential to translate into the clinic within five years.
Apply for funding
Involving people with Parkinson’s in research
People with Parkinson’s are an essential part of our programme of research. It is important that drug candidates chosen for scientific reasons are also of relevance to people living with Parkinson’s now. For support with involving people living with Parkinson’s in a research study or trial, please get in touch.
Contact us
Journal of Parkinson’s Disease
Our partner for the regular webinar series, the Journal of Parkinson’s Disease, is dedicated to providing an open forum for original research in basic science, translational research, and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal welcomes submissions via its website.
Find out more
Clinical Trials Charter
The Cure Parkinson’s Clinical Trials Charter aims to set a standard of practice for those involved in clinical trials for Parkinson’s.
Read more here
Science of Parkinson’s blog
Written by Dr Simon Stott (Deputy Director of Research, Cure Parkinson’s), this is Simon’s personal and independent perspective of what is happening in the world of Parkinson’s research, with regular updates detailing the science behind new discoveries, up to date clinical trial results, and introducing some of the people behind the research.
Read more here
The Tom Isaacs Award
Each year the Tom Isaacs Award is presented to the researcher who has shown the greatest impact on the lives of people living with Parkinson’s and/or has involved people with Parkinson’s in a participatory way in their work.
Find out more, and nominate
3P seminars
Calling all early or mid career researchers! The 3P platform was created during lockdown as a way of allowing early career scientists the opportunity to present and discuss their research online to the scientific community, thereby continuing their professional development. Cure Parkinson’s, Van Andel Institute and World Parkinson Coalition co-host these interactive presentations focused on neurodegenerative research.
Find out more
Our pre-clinical research
We are an international funder of both preclinical and clinical research.
The preclinical research we fund must be focussed on changing the course of Parkinson’s (disease modifying) and must be within 5 years of reaching the clinic.
The AMRC Best Practice Guidance
Cure Parkinson’s is a member of the Association of Medical Research Charities (AMRC). We follow AMRC requirements and guidance for best practice in research. AMRC charities are obliged to follow rigorous research evaluation (peer review) processes to ensure that only research of the highest quality is supported. Cure Parkinson’s has received a certificate of best practice in medical and health research peer review evaluated by the AMRC in their 2020 Peer Review Audit. The AMRC audits their member charities every 5 years to ensure that research funding applications are evaluated in accordance with their principles of peer review: accountability, balance, independent decision making, rotation of scientific advisers and impartiality.
To support our researchers and help build knowledge of AMRC Open Research and how it works, they are hosting a series of educational webinars. The first in this series is the Open Data Essentials webinar on the 23 March 2022
